Comprehensive Plan for Addressing High Drug Prices: A Report in Response to the Executive Order on Competition in the American Economy, Report to the White House Competition Council [open pdf - 1MB]
From the Executive Summary: "President Biden's Executive Order 14036, 'Promoting Competition in the American Economy' (the Competition Executive Order), identifies a lack of competition as a key driver for problems across economic sectors. The Report presents principles for equitable drug pricing reform through competition, innovation, and transparency; describes promising legislative approaches; and summarizes actions already underway or under consideration across the Department of Health and Human Services (HHS). In the course of preparing the Report, Secretary Xavier Becerra, other HHS officials, and HHS staff held listening sessions with consumer groups, staff from the Medicare Payment Advisory Commission (MedPAC), independent experts and researchers, and stakeholders from across the health care system. Americans spend more than $1,500 per person on prescription drugs and pay prices that are far higher than any comparable nation. Prices for brand name drugs are rising faster than inflation. Many Americans do not take medications as prescribed because of their cost, with resulting harm to their health care and health. Lack of competition is a key factor in these high drug costs."
Office of the Assistant Secretary for Planning and Evaluation: https://aspe.hhs.gov/